skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 3
Patent #:
Issue Dt:
10/15/2019
Application #:
15813001
Filing Dt:
11/14/2017
Publication #:
Pub Dt:
08/09/2018
Inventors:
Leticia M. Toledo-Sherman, Celia Dominguez, Michael Prime, William Leonard Mitchell et al
Title:
KYNURENINE-3-MONOOXYGENASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF
Assignment: 1
Reel/Frame:
045543/0001Recorded: 03/23/2018Pages: 5
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
10/13/2014
Assignee:
350 SEVENTH AVENUE
SUITE 200
NEW YORK, NEW YORK 10001
Correspondent:
SHEPPARD MULLIN RICHTER & HAMPTON, LLP
379 LYTTON AVE.
LORNA L. TANNER
PALO ALTO, CA 94301
Assignment: 2
Reel/Frame:
045692/0441Recorded: 03/23/2018Pages: 4
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
10/13/2014
Exec Dt:
10/13/2014
Exec Dt:
10/13/2014
Exec Dt:
10/14/2014
Assignee:
114 MILTON PARK
ABINGDON OXFORDSHIRE, UNITED KINGDOM OX14 4SA
Correspondent:
SHEPPARD MULLIN RICHTER & HAMPTON, LLP
379 LYTTON AVE.
LORNA L. TANNER
PALO ALTO, CA 94301
Assignment: 3
Reel/Frame:
045692/0387Recorded: 03/23/2018Pages: 4
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
10/27/2014
Exec Dt:
10/27/2014
Assignee:
350 SEVENTH AVENUE
SUITE 200
NEW YORK, NEW YORK 10001
Correspondent:
SHEPPARD MULLIN RICHTER & HAMPTON, LLP
379 LYTTON AVE.
LORNA L. TANNER
PALO ALTO, CA 94301

Search Results as of: 05/12/2024 01:31 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT